至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

High level expression, purification and immunogenicity analysis of a protective recombinant protein against botulinum neurotoxin type E.

World J Microbiol Biotechnol. 2014; 
Valipour E, Moosavi ML, Amani J, Nazarian S.
Products/Services Used Details Operation
Codon Optimization … 1,302 bp) was extracted from NCBI website (Gene Bank = DQ512735.1), then C + G contents and codon usage of the wild-type BoNT/E-Hcc sequence was optimized according to the E. coli expression system by using websites http://eu.idtdna.com, http://www.genscript.com and … Get A Quote

摘要

Botulinum neurotoxin type E heavy chain consists of two domains: N-terminal half as a translocation domain and C-terminal half (Hcc) as a binding domain. In this research a synthetic gene fragment encoding the binding domain of botulinum neurotoxin type E (BoNT/E-Hcc) was highly expressed in Escherichia coli by pGEX4T-1 vector. After purification, the recombinant BoNT/E-Hcc was evaluated by SDS-PAGE and western blot (immunoblot) analysis. Average yields obtained in this research were 3.7 mg recombinant BoNT/E-Hcc per liter of bacterial culture. The recombinant protein was injected in mice for study of its protection ability against botulinum neurotoxin type E challenges. The challenge studies showed that, vacci... More

关键词